AzTrials
AzTrials

Peripheral Nerve InjuriesNCT03359330

Mid-term Effect Observation of Biodegradable Conduit Small Gap Tublization Repairing Peripheral Nerve Injury

An observational study of Peripheral Nerve Injuries, run by Peking University People's Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To observe the Mid-term clinical effect of biodegradable conduit small gap tublization to repair peripheral nerve injury in multi-center. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Peripheral Nerve Injuries
What is being tested?
Degradable Conduit Small Gap Tublization
How many people
150 participants
Where
No sites listed yet
Study dates
1 Jan 2018to 31 Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients with fresh peripheral nerve injury in the upper extremities, requiring surgery

Who may be able to join

  • fresh peripheral nerve injury in the upper extremities

Who cannot join

  • acute myocardial infarction history within 6 months,
  • old and pathological peripheral nerve injury,
  • acute and chronic infection,
  • various consumptive diseases
  • unable to tolerate surgery

Trial locations and contacts

No sites are listed yet.

Peixun Zhang, MD contact

0118613611237628

zhangpeixun@126.comb

About this study

Official title: A Multi-center Study on Mid-term Effect Observation of Biodegradable Conduit Small Gap Tublization Repairing Peripheral Nerve Injury

To observe the Mid-term clinical effect of biodegradable conduit small gap tublization to repair peripheral nerve injury in multi-center.

Read the detailed description

In the study,150 cases of fresh peripheral nerve injury in the upper extremities are recruited in multi-center. After formally informed and obtaining the consent,the biodegradable conduit small gap tublization are used to repair the nerve.Their nerve functional recovery conditions are clinically observed according to the standard score methods provided by SHEN Ning-jiang and British Medical Research Council at 3 years after surgery.The excellent and good rates of the overall nerve functional recovery are calculated.

Being tested
Degradable Conduit Small Gap Tublization
Keywords
Peripheral nervous system diseases, Wounds and injuries, Nerve regeneration, Biocompatible materials, Surgical procedures
Medical subject headings
Peripheral Nerve Injuries, Peripheral Nervous System Diseases, Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Degradable Conduit Small Gap TublizationOther

    Degradable Conduit Small Gap Tublization Repairing Peripheral Nerve Injury

Study groups in NCT03359330
Study groupRoleWhat they receive
Degradable conduit small gap tublizationpatients with fresh peripheral nerve injury in the upper extremities,repaired with degradable conduit small gap tublization
Receives: Other: Degradable Conduit Small Gap Tublization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nerve function 1

    standard score methods provided by British Medical Research Council

    Measured: 3 years after surgery

Secondary outcomes (1)
  1. Nerve function 2

    standard score methods provided by Shen Ningjiang Using MSA system

    Measured: 3 years after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2017
  2. Study start1 Jan 2018 (estimated)
  3. Primary completion31 Dec 2021 (estimated)
  4. Study completion31 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03359330
Sponsor's protocol ID
PKUPH-PNI
Status last verified
Nov 2017
First submitted
26 Nov 2017
Last updated
2 Dec 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Peripheral Nerve Injuries, run by Peking University People's Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Peixun Zhang, MD (0118613611237628, zhangpeixun@126.comb), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nerve function 1 (time frame: 3 years after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Dec 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in